Management of Bloodstream Infections in Left Ventricular Assist Device Recipients: To Suppress, or Not to Suppress?
Zerelda Esquer GarrigosDeeksha JandhyalaPrakhar VijayvargiyaNatalia E Castillo AlmeidaPooja GurramCristina G Corsini CampioliJohn M StulakStacey A RizzaJohn C O'HoroDaniel C DeSimoneLarry M BaddourM Rizwan SohailPublished in: Open forum infectious diseases (2020)
Patients presenting with LVAD-related BSI are at high risk of relapse. Consequently, CAS therapy may be a reasonable approach in the management of these cases. In contrast, routine use of CAS therapy may be unnecessary for non-LVAD BSIs.